<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00869219</url>
  </required_header>
  <id_info>
    <org_study_id>SCMisericordiaSantos</org_study_id>
    <nct_id>NCT00869219</nct_id>
  </id_info>
  <brief_title>Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)</brief_title>
  <official_title>Phase 4 Study of Topical NSAID for Ophthalmologic Use: Pain Measurement After First Drop.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Santa Casa de Misericordia de Santos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Santa Casa de Misericordia de Santos</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Different case reports are showing that depending on the drug used for eye drops, it might
      provoke a painful sensation. Actually two leading NSAIDs are used in ophthalmology. This
      study is intended to provide information about this parameter concerning these two drugs.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">August 2009</completion_date>
  <primary_completion_date type="Anticipated">August 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain after instilation</measure>
    <time_frame>5 min</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Nevanac</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Acular LS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nevanac</intervention_name>
    <description>1 drop of NEVANAC at random eye</description>
    <arm_group_label>Nevanac</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acular LS</intervention_name>
    <description>One drop of Acular LS</description>
    <arm_group_label>Acular LS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient over 21 years old

          -  No ocular surface pathology

          -  Eligible for cataract surgery

        Exclusion Criteria:

          -  Any other eye pathology other than cataract
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gustavo T Grottone, MD, MBA,MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>SCMS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jo√£o C Grottone, MD, MBA</last_name>
    <role>Study Chair</role>
    <affiliation>SCMS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gustavo T Grottone, MD, MBA, MSc</last_name>
    <phone>551381515130</phone>
    <email>gtg2001@terra.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Santa Casa de Misericordia de Santos</name>
      <address>
        <city>Santos</city>
        <state>Sao Paulo</state>
        <zip>11055360</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gustavo T Grottone, MD, MBA, MSc</last_name>
      <phone>551381515130</phone>
      <email>gtg2001@terra.com.br</email>
    </contact>
    <investigator>
      <last_name>Gustavo T Grottone, MD, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2009</study_first_submitted>
  <study_first_submitted_qc>March 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 25, 2009</study_first_posted>
  <last_update_submitted>March 25, 2009</last_update_submitted>
  <last_update_submitted_qc>March 25, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 26, 2009</last_update_posted>
  <responsible_party>
    <name_title>Gustavo Teixeira Grottone</name_title>
    <organization>Santa Casa de Misericordia de Santos</organization>
  </responsible_party>
  <keyword>Pain</keyword>
  <keyword>Pain after eyedrops</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
    <mesh_term>Ketorolac Tromethamine</mesh_term>
    <mesh_term>Ketorolac</mesh_term>
    <mesh_term>Nepafenac</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

